Carlsmed insider buys 200,000 shares at $15

Rhea-AI Filing Summary

CARLSMED, INC. (CARL) reported that Casey M. Tansey, identified as a ten percent owner, purchased 200,000 shares of common stock on July 24, 2025 in an open-market or private transaction at $15.00 per share. Following this transaction, Tansey is reported as holding 200,000 shares, with the stock held by Casey M. Tansey as noted in the footnote. The amendment corrects an earlier Form 4 that omitted this purchase, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Net Buyer: 200,000 shares

Net Buy 1 txn

Insider Presidio Management Group XII, L.L.C., U.S. Venture Partners XII, L.P., Tansey Casey M

Role 10% Owner | 10% Owner | 10% Owner

Bought 200,000 shs ($3.00M)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	200,000	$15.00	$3.00M

Holdings After Transaction: Common Stock — 200,000 shares (Indirect, See footnote)

Footnotes (1)

1. F1. Stock held by Casey M. Tansey.

Key Figures

Shares purchased: 200,000 shares Purchase price per share: $15.00 per share Shares held after transaction: 200,000 shares +1 more

4 metrics

Shares purchased 200,000 shares Common stock purchased by Casey M. Tansey on July 24, 2025

Purchase price per share $15.00 per share Price paid for CARLSMED, INC. common stock on July 24, 2025

Shares held after transaction 200,000 shares Common stock holdings of Casey M. Tansey following the reported purchase

Number of buy transactions reported 1 transaction Single open-market or private purchase reported in the Form 4/A

Key Terms

ten percent owner, indirect ownership, Rule 10b5-1, open market or private transaction

4 terms

ten percent owner regulatory

"identified as a ten percent owner"

indirect ownership regulatory

"ownership type reported as indirect with nature of ownership footnoted"

Rule 10b5-1 regulatory

"no Rule 10b5-1 trading plan is reported"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

open market or private transaction financial

"Purchase in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CARL disclose in this amended Form 4?

The amendment reports that Casey M. Tansey, a ten percent owner, purchased 200,000 shares of CARLSMED, INC. common stock on July 24, 2025 at $15.00 per share, and now holds 200,000 shares after the transaction.

Why did CARLSMED, INC. (CARL) file this Form 4/A amendment?

The amendment was filed to correct an administrative error in a prior Form 4 that omitted the 200,000-share purchase by Casey M. Tansey and mistakenly indicated he did not directly own any shares of CARLSMED, INC. common stock.

How many CARL shares did Casey M. Tansey buy and at what price?

Casey M. Tansey bought 200,000 shares of CARLSMED, INC. common stock at a price of $15.00 per share on July 24, 2025, in a transaction described as an open-market or private purchase.

What is Casey M. Tansey’s reported CARL shareholding after this transaction?

After the July 24, 2025 purchase, Casey M. Tansey is reported as holding 200,000 shares of CARLSMED, INC. common stock. The footnote specifies that the stock is held by Casey M. Tansey.

Was the CARL insider trade under a Rule 10b5-1 trading plan?

No. The filing indicates that no Rule 10b5-1 trading plan applies to this transaction, meaning the reported July 24, 2025 purchase was not affirmed as made under a pre-arranged trading plan.

Who are the reporting persons in this CARL Form 4/A filing?

The reporting persons are Presidio Management Group XII, L.L.C., U.S. Venture Partners XII, L.P., and Casey M. Tansey, each identified as a ten percent owner of CARLSMED, INC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/15/2026 - 05:07 PM Accepted by SEC EDGAR 09/15/2026 - 05:07 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Presidio Management Group XII, L.L.C.

(Last) (First) (Middle)

C/O U.S. VENTURE PARTNERS

1460 EL CAMINO REAL, SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CARLSMED, INC. [ CARL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)
07/24/2025

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/24/2025		P		200,000	A	$15	200,000	I	See footnote(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person^*

Presidio Management Group XII, L.L.C.

(Last) (First) (Middle)

C/O U.S. VENTURE PARTNERS

1460 EL CAMINO REAL, SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

U.S. Venture Partners XII, L.P.

(Last) (First) (Middle)

1460 EL CAMINO REAL, SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

1. Name and Address of Reporting Person^*

Tansey Casey M

(Last) (First) (Middle)

1460 EL CAMINO REAL, SUITE 100

(Street)

MENLO PARK CALIFORNIA 94025

(City) (State) (Zip)

UNITED STATES

(Country)

Relationship of Reporting Person(s) to Issuer

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

Explanation of Responses:

1. Stock held by Casey M. Tansey.

Remarks:

On July 24, 2025, the Reporting Persons filed a Form 4 which, due to an administrative error, inadvertently omitted the purchase of common stock by Mr. Tansey and indicated that he did not directly own any shares of the Issuer's common stock. This Form 4 is being filed solely to correct that error and report the purchase by Mr. Tansey.

	/s/ Dale Holladay, Authorized Signatory on behalf of Presidio Management Group	09/15/2026
	/s/ Dale Holladay, Authorized Signatory on behalf of U.S. Venture Partners XII, L.P.	09/15/2026
	/s/ Dale Holladay, Attorney-in-Fact for Casey M. Tansey	09/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)